Weill Cornell awarded $11.3 million SPORE grant for prostate cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Weill Cornell Medicine was awarded a five-year, $11.3 million Specialized Programs of Research Excellence grant from NCI to improve the detection, diagnosis and treatment of prostate cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login